CD8A and primary cutaneous T-cell non-Hodgkin lymphoma: Previously, it has been demonstrated that a higher CD8+ T cell infiltrate in the skin is correlated with better prognosis in patients across plaque-stage MF, tumor stage MF, and CD30- PCTCL, and is correlated with less aggressive disease [24].